Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Zhoushan Putuo Xinxing Pharmas Co., Ltd. (PXPC) is a specialized manufacturer of chitin and glucosamine-based products, established in 1993 and headquartered in Zhoushan, China. The company utilizes local marine resources to produce a range of active pharmaceutical ingredients (APIs) and dietary supplements, including glucosamine hydrochloride, glucosamine sulfate, and chitosan. PXPC operates three manufacturing plants covering over 60,000 square meters and maintains rigorous quality standards, holding NSF GMP, ISO 9001, and NMPA Drug Manufacturing Licenses. Its products are primarily indicated for the treatment of osteoarthritis and general joint health, and are exported to major international markets including Europe, North America, and Japan. The company is recognized for its research and development in marine-derived biochemicals and holds multiple US FDA Drug Master Files (DMFs).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhoushan Putuo Xinxing Pharmachem.